This protocol is judged by an institutional overview board, an unbiased group that reviews any clinical trials involving humans. If a research includes a Agenda I drug, as soon as the board approves the protocol as moral, the scientists have to make an application for an investigational new drug (IND) selection in the FDA.Weiser urged social websi